Back to Markets
ALAlumis Inc

Alumis Inc

ALMSNASDAQ NMS - GLOBAL MARKET
Health CarePharmaceuticals

$21.60

+0.2000 (+0.93%)

As of 05/29/26 EDT · USD

Compare
Low: $2.76Current: $21.60High: $30.60

Key Statistics

Open

$21.37

Day High

$21.65

Day Low

$20.99

Prev. Close

$21.40

VolumeShares traded today.

919.15K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$2.75B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-11.24

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$30.60

52W LowLowest price over the past 52 weeks.

$2.76

50D MAAverage closing price over the last 50 trading days.

$23.62

200D MAAverage closing price over the last 200 trading days.

$15.44

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-2.6%

1M

-5.6%

6M

+194.7%

YTD

+141.2%

1Y

+556.5%

About

Acelyrin, Inc. is a late-stage clinical biopharmaceutical company headquartered in Agoura Hills, California, with additional operations in the San Francisco Bay Area.

www.alumis.com/

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ALMS

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.